1. |
Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab, 2013, 98(3): 1122-1129.
|
2. |
Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, et al. Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. World J Surg, 2016, 40(10): 2359-2377.
|
3. |
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer1, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11): 1167-1214.
|
4. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
|
5. |
刘宁, 韩彬, 韦伟. 纳米碳负显影甲状旁腺在甲状腺癌手术中的应用价值. 广东医学, 2014, 35(12): 1918-1920.
|
6. |
朱精强, 汪洵理, 魏涛, 等. 纳米碳甲状旁腺负显影辨认保护技术在甲状腺癌手术中的应用. 中国普外基础与临床杂志, 2013, 20(9): 992-994.
|
7. |
中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺手术中甲状旁腺保护专家共识. 中国实用外科杂志, 2015, 35(7): 731-736.
|
8. |
Eastell R, Brandi ML, Costa AG, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab, 2014, 99(10): 3570-3579.
|
9. |
Bilezikian JP, Khan AA, Potts JT Jr; Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism.Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab, 2009, 94(2): 335-339.
|
10. |
Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab, 2002, 87(12): 5353-5361.
|
11. |
Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease—a review. Eur Heart J, 2004, 25(20): 1776-1787.
|
12. |
Cansu GB, Yılmaz N, Özdem S, et al. Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness. Clin Endocrinol (Oxf), 2016, 84(1): 39-47.
|
13. |
Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of hyperparathyroidism. J Clin Pathol, 2015, 68(10): 771-787.
|
14. |
Zanocco KA, Wu JX, Yeh MW. Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction. Surgery, 2017, 161(1): 16-24.
|
15. |
Maruani G, Hertig A, Paillard M, et al. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab, 2003, 88(10): 4641-4648.
|
16. |
Bergenfelz A, Lindblom P, Lindergård B, et al. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism. World J Surg, 2003, 27(4): 481-485.
|
17. |
Kösem M, Algün E, Kotan C, et al. Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery. Acta Chir Belg, 2004, 104(5): 568-571.
|
18. |
Lee JK, Obrzut SL, Yi ES, et al. Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism. Endocr Pract, 2007, 13(4): 380-383.
|
19. |
Riss P, Kammer M, Selberherr A, et al. Morbidity Associated with Concomitant Thyroid Surgery in Patients with Primary Hyperparathyroidism. Ann Surg Oncol, 2015, 22(8): 2707-2713.
|
20. |
Niedźwiecki S, Kuzdak K, Kaczka K, et al. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer—preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology. Wiad Lek, 2007, 60(5-6): 228-230.
|
21. |
苏磊, 王雪晨, 姚永忠, 等. 原发性甲状旁腺功能亢进症合并甲状腺疾病的诊治体会. 中国普外基础与临床杂志, 2010, 17(12): 1290-1293.
|
22. |
Bilezikian JP, Silverberg SJ, Rubin M, Jr JTP. Asymptomatic primary hyperparathyroidism: Present management and future options. 2006;3:132-40.
|
23. |
Morris GS, Grubbs EG, Hearon CM, et al. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg, 2010, 251(5): 832-837.
|
24. |
中华医学会骨质疏松和骨矿盐疾病分会, 中华医学会内分泌分会代谢性骨病学组. 原发性甲状旁腺功能亢进症诊疗指南. 中华骨质疏松和骨矿盐疾病杂志, 2014, 7(3): 187-198.
|
25. |
朱信心, 魏涛, 龚日祥, 等. 136 例原发性甲状旁腺功能亢进的诊治体会. 中国普外基础与临床杂志, 2014, 21(4): 452-457.
|
26. |
胡章, 张纯海. 原发性甲状旁腺功能亢进症的临床资料分析. 吉林大学, 2016.
|
27. |
吴全, 崔爱民, 柏楠, 等. 73 例原发性甲状旁腺功能亢进症的诊治分析. 中国普外基础与临床杂志, 2013, 20(7): 776-781.
|